Literature DB >> 24999540

Xylitol and its usage in ENT practice.

Ö Sakallioğlu1, I Adadan Güvenç2, C Cingi3.   

Abstract

BACKGROUND: Xylitol is a five-carbon sugar alcohol. Natural sources of xylitol include plums, strawberries and raspberries. Xylitol is commercially available in chewing gums, lozenges, syrups, nasal sprays, toothpastes, mouthwashes and other products in some countries. It has gained relative prominence in the past decade as a naturally occurring antibacterial agent.
OBJECTIVE: A review of contemporary literature was conducted to evaluate the efficacy of xylitol usage in ENT practice.
METHOD: The English-language literature was searched using the following terms: xylitol, otitis media, nasal, sinusitis, dental caries and preventive therapy. The articles identified were included in this review.
RESULTS: Xylitol has no antibacterial properties of its own; rather, it appears to enhance the body's own innate immunity. Xylitol has anti-adhesive effects on micro-organisms like Streptococcus pneumoniae and Streptococcus mutans, inhibiting their growth. Xylitol has already been used for preventing otitis media, rhinosinusitis and dental caries. The worldwide spread of drug-resistant strains of pneumococci substantiates the need for new approaches to prevent ENT-related infectious diseases.
CONCLUSION: Xylitol may be a promising agent for this purpose in ENT practice, but further experimental and clinical studies are required.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24999540     DOI: 10.1017/S0022215114001340

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

Review 1.  Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).

Authors:  Victor B Hsue; Kyohei Itamura; Arthur W Wu; Elisa A Illing; Kevin J Sokoloski; Bree A Weaver; Benjamin P Anthony; Nathan Hughes; Jonathan Y Ting; Thomas S Higgins
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.

Authors:  Shruti Bansal; Colleen B Jonsson; Shannon L Taylor; Juan Manuel Figueroa; Andrea Vanesa Dugour; Carlos Palacios; Julio César Vega
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.